Endocannabinoid and Opioid System Interactions in Exercise-Induced Hypoalgesia.

OBJECTIVE.:

The purpose of this study was to examine the interaction between the endogenous opioid and endocannabinoid (eCB) systems in a pain modulatory process known as exercise-induced hypoalgesia (EIH).

DESIGN.:

Randomized controlled trial.

SETTING.:

Clinical research unit in a hospital.

SUBJECTS.:

Fifty-eight healthy men and women (mean age = 21 ± 3 years) participated in this study.

METHODS:

. Participants were administered (randomized, double-blind, counterbalanced procedure) an opioid antagonist (i.e., naltrexone) and a placebo prior to performing pain testing and isometric exercise.

RESULTS.:

Results indicated that 2-arachidonoylglycerol (2-AG) and 2-oleoylglycerol (2-OG) increased significantly ( P  < 0.05) following exercise in both placebo and naltrexone conditions. In comparison, N-arachidonylethanolamine (AEA) and oleoylethanolamine (OEA) increased significantly ( P  < 0.05) following exercise in the placebo condition but not the naltrexone condition. There were no significant ( P  > 0.05) differences in palmitolethanolamine (PEA) between the placebo and naltrexone conditions.

CONCLUSIONS.:

As reductions in pain (i.e., EIH) were observed following both conditions, these results suggest that the opioid system may not be the primary system involved in exercise-induced hypoalgesia and that 2-AG and 2-OG could contribute to nonopioid exercise-induced hypoalgesia. Moreover, as exercise-induced increases in AEA and OEA were blocked by naltrexone pretreatment, this suggests that the opioid system may be involved in the increase of AEA and OEA following exercise.